| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |